Position
SIMPLEX TRADING, LLC in Lyell Immunopharma, Inc.
Back to the book · All holders of LYEL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$396$30.76 → $20.06
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 37 | $1.14K | — | — | — | 0.0% |
| Q1 2026 | 693 | $13.9K | $20.06 | −$396 | $13.2K | 0.0% |